Evidence-based medicine: An update on treatments for peritoneal dialysis-related peritonitis

doi:10.5527/wjn.v4.i2.287

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8007)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

623

WORD

306

HTML

4112

Figures (1-2)

170

Tables (1-1)

181

Sum=5392

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1041

Download

1574

Sum=2615

May 6, 2015 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Nephrol. May 6, 2015; 4(2): 287-294
Published online May 6, 2015. doi: 10.5527/wjn.v4.i2.287

Full Size Figure Download Figure

Figure 1 Combined resolution rate and 95%CIs of studies on initial treatment of peritoneal dialysis-related peritonitis with ceftazidime plus a glycopeptide vs a first generation cephalosporin plus an aminoglycoside.

Citation: Barretti P, Doles JVP, Pinotti DG, El Dib RP. Evidence-based medicine: An update on treatments for peritoneal dialysis-related peritonitis. World J Nephrol 2015; 4(2): 287-294
URL: https://www.wjgnet.com/2220-6124/full/v4/i2/287.htm
DOI: https://dx.doi.org/10.5527/wjn.v4.i2.287